AnalystsMichael Schmidt
Michael Schmidt's Stock Forecasts

Analyst Ranking
Top 2%
#92 out of 5563 analysts
Average Return
+36%
Win Rate
57%90 out of 158
Risk vs Reward
Poor
Good

Michael Schmidt's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Nanobiotix SaNBTX
+850.69%$3.27$31.04
2025-04-04 -
2026-04-02
Strong Buy
Urogen Pharma LtdURGN
+613.13%$4.19$29.88
2025-05-23 -
2026-05-21
Strong Buy
Tango Therapeutics IncTNGX
+342.92%$6.50$28.79
2025-08-06 -
2026-08-05
Strong Buy
Revolution Medicines IncRVMD
+341.99%$38.41$169.77
2025-06-25 -
2026-06-24
Strong Buy
Relay Therapeutics IncRLAY
+337.97%$2.95$12.92
2025-05-07 -
2026-05-06
Strong Buy

Michael Schmidt Analyst Color

Get additional color on Michael Schmidt's coverage of popular stocks

Michael Schmidt's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Arrivent Biopharma IncAVBP
5Strong Buy$28.00+156.88%Maintains
4 days ago
Enliven Therapeutics IncELVN
1Strong Buy$78.00+73.76%Reiterates
14 days ago
Damora Therapeutics IncDMRA
1Strong Buy$59.00+156.74%Maintains
14 days ago
C4 Therapeutics IncCCCC
2Strong Buy$6.00+142.42%Maintains
14 days ago
Celcuity IncCELC
1Strong Buy$169.00+203.96%Maintains
14 days ago
Urogen Pharma LtdURGN
2Strong Buy$56.00+87.98%Maintains
15 days ago
Faeth Therapeutics IncFTH
1Strong Buy$69.00+691.28%Maintains
16 days ago
Genmab AGMAB
7Strong Buy$80.00+56.96%Maintains
21 days ago
Foghorn Therapeutics IncFHTX
2Strong Buy$5.00+179.33%Maintains
2 months ago
Compass Therapeutics IncCMPX
7Strong Buy$4.00+554.66%Maintains
2 months ago
Blossomhill Therapeutics IncBLSM
1Strong Buy$30.00+105.62%Initiates Coverage On
3 months ago
Monte Rosa Therapeutics IncGLUE
6Strong Buy$28.00+208.71%Reiterates
3 months ago
Adc Therapeutics SaADCT
7Strong Buy$5.00+264.96%Maintains
3 months ago
Cogent Biosciences IncCOGT
2Strong Buy$52.00+86.98%Maintains
3 months ago
Tango Therapeutics IncTNGX
4Strong Buy$35.00+59.89%Maintains
3 months ago
Cytomx Therapeutics IncCTMX
4Strong Buy$14.00+644.68%Maintains
3 months ago
Verastem IncVSTM
4Strong Buy$12.00+74.67%Maintains
3 months ago
Revolution Medicines IncRVMD
9Strong Buy$240.00+50.17%Maintains
3 months ago
Parabilis Medicines IncPBLS
1Strong Buy$40.00+40.50%Initiates Coverage On
4 months ago
Engene Therapeutics IncENGN
1HoldN/AN/ADowngrades
6 months ago
Beone Medicines LtdONC
10Strong Buy$420.00+4.06%Maintains
6 months ago
Zentalis Pharmaceuticals IncZNTL
5Strong Buy$10.00+635.29%Maintains
7 months ago
Nanobiotix SaNBTX
4Strong Buy$36.00+33.83%Maintains
8 months ago
Erasca IncERAS
2Strong Buy$20.00+45.35%Maintains
8 months ago
X4 Pharmaceuticals IncXFOR
1Strong Buy$12.00+302.68%Initiates Coverage On
8 months ago
Immunome IncIMNM
4Strong Buy$35.00+108.58%Maintains
a year ago
Incyte CorpINCY
7Strong Buy$125.00N/AUpgrades
a year ago
Mersana Therapeutics IncMRSN
4Strong Buy$30.00N/AMaintains
a year ago
Oric Pharmaceuticals IncORIC
5Strong Buy$18.00N/AReiterates
a year ago
Arvinas IncARVN
6Strong Buy$15.00N/AMaintains
a year ago
Kymera Therapeutics IncKYMR
1Strong Buy$52.00N/AReiterates
2 years ago
Springworks Therapeutics IncSWTX
3Hold$47.00N/AReiterates
2 years ago
Relay Therapeutics IncRLAY
1Strong Buy$10.00N/AMaintains
2 years ago
Syndax Pharmaceuticals IncSNDX
3Strong Buy$32.00N/AReiterates
2 years ago
Merus NvMRUS
5Strong Buy$109.00N/AReiterates
2 years ago
Adaptimmune Therapeutics PLCADAPY
3Strong Buy$1.75N/AMaintains
2 years ago
Legend Biotech CorpLEGN
1HoldN/AN/AReiterates
2 years ago
Exelixis IncEXEL
7Strong Buy$42.00N/AReiterates
2 years ago
Century Therapeutics IncIPSC
1Strong BuyN/AN/AReiterates
2 years ago
Blueprint Medicines CorpBPMC
2Strong BuyN/AN/AReiterates
2 years ago
Protara Therapeutics IncTARA
1Strong Buy$20.00N/AReiterates
2 years ago
Immunocore Holdings PLCIMCR
3HoldN/AN/ADowngrades
2 years ago
Adicet Bio IncACET
4Strong Buy$112.00N/AUpgrades
2 years ago
Bolt Biotherapeutics IncBOLT
2HoldN/AN/ADowngrades
3 years ago
Deciphera Pharmaceuticals IncDCPH
2HoldN/AN/ADowngrades
3 years ago
Immuneering CorpIMRX
2HoldN/AN/ADowngrades
3 years ago
Allogene Therapeutics IncALLO
1HoldN/AN/ADowngrades
3 years ago
Immunogen IncIMGN
1Hold$31.00N/ADowngrades
3 years ago
Xencor IncXNCR
2Strong Buy$34.00N/AMaintains
3 years ago
Mirati Therapeutics IncMRTX
4Strong Buy$60.00N/AMaintains
3 years ago
Seagen IncSGEN
3Strong Buy$170.00N/AReiterates
4 years ago
Neurogene IncNGNE
2HoldN/AN/ADowngrades
4 years ago
Rubius Therapeutics IncRUBY
2HoldN/AN/ADowngrades
4 years ago
Rain Oncology IncRAIN2
1Strong Buy$26.00N/AInitiates Coverage On
6 years ago
Cellectis SaCLLS
1HoldN/AN/ADowngrades
6 years ago
Immunomedics IncIMMU
1Strong Buy$39.00N/AMaintains
7 years ago
Spectrum Pharmaceuticals IncSPPI
1HoldN/AN/ADowngrades
7 years ago
Forty Seven IncFTSV
1Strong Buy$48.00N/AMaintains
7 years ago
Bluebird Bio IncBLUE
4HoldN/AN/ADowngrades
8 years ago
Agios Pharmaceuticals IncAGIO
3Buy$80.00N/AUpgrades
8 years ago
Array Technologies IncARRY
3BuyN/AN/AInitiates Coverage On
8 years ago
Clovis Oncology IncCLVSQ
2Hold$30.00N/AInitiates Coverage On
8 years ago
Five Prime Therapeutics IncFPRX
1Buy$24.00N/AReinstates
8 years ago
Juno Therapeutics IncJUNO
2Hold$87.00N/ADowngrades
9 years ago
Arbutus Biopharma CorpABUS
1Hold$5.50N/AMaintains
9 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.